Epigenetic Aging and Rheumatoid Arthritis
Эпигенетическое старение и ревматоидный артрит
2023-09-12
SCID: 54.1/uz6au6ga
Discuss with AI
DNA methylationGrimAgeepigenetic age accelerationepigenetic agingrheumatoid arthritis
Figures from the paper
Abstract (AI)
This is the first known comparative assessment of the associations of epigenetic age estimates with the prevalence of rheumatoid arthritis (RA). We used data available in Gene Expression Omnibus (GSE42861) from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Information regarding RA diagnosis and 450K DNA methylation (DNAm) of 18- to 70-year-old participants was available. Utilizing Horvath's online DNAm Age Calculator, we determined the DNAm estimate of Telomere length (DNAmTL), Hannum's epigenetic age, Horvath's 2013 and 2018 epigenetic ages, PhenoAge, GrimAge, and the respective age-acceleration measures. The association of RA prevalence with epigenetic age measures was assessed using linear regression, adjusting for sex and smoking status. The p values were corrected for multiple testing using a false discovery rate. We identified statistically significant associations of RA with Horvath 2013 age acceleration (estimate: -1.34; FDR p value: 1.0 × 10-2), Horvath 2018 age acceleration (estimate: -1.32; FDR p value: 4.0 × 10-5), extrinsic age acceleration (estimate: 1.34; FDR p value: 1.0 × 10-2), PhenoAge acceleration (estimate: 2.31; FDR p value: 1.1 × 10-5), GrimAge (estimate: 2.54; FDR p value: 1.0 × 10-2), and GrimAge acceleration (estimate: 3.15; FDR p-value: 1.7 × 10-17). Of note, the raw and age-adjusted GrimAge surrogate DNAm protein components were significantly higher in RA cases than controls. Interestingly, the first-generation measures were associated only with women. No sex-specific effects were identified for PhenoAge or GrimAge accelerations. In this cross-sectional assessment, the second-generation clocks show promise as markers of biological aging, with higher epigenetic age acceleration observed in RA cases compared with healthy controls.
Key Findings
1
First-generation epigenetic age measures were associated with RA only among women, whereas PhenoAge and GrimAge acceleration showed no sex-specific effects.
2
In this cross-sectional study, second-generation epigenetic clocks showed promise as markers of biological aging in rheumatoid arthritis.
3
RA cases showed significantly higher PhenoAge acceleration (estimate 2.31), GrimAge (estimate 2.54), and GrimAge acceleration (estimate 3.15; FDR p=1.7 × 10⁻¹⁷).
4
Raw and age-adjusted GrimAge surrogate DNA methylation protein components were significantly higher in rheumatoid arthritis cases than controls.
5
Rheumatoid arthritis was significantly associated with lower Horvath 2013 and 2018 age acceleration, but higher extrinsic age acceleration after adjustment for sex and smoking.
6
This study provides the first comparative assessment of associations between multiple DNA methylation-based epigenetic aging measures and rheumatoid arthritis prevalence.
Research Object
Adults with and without rheumatoid arthritis (RA), assessed using 450K DNA methylation profiles
Research Subject
Associations between rheumatoid arthritis prevalence and epigenetic age estimates and age-acceleration measures
Publication Details
Publication Date
2023-09-12
Journal
Publisher
ISSN
Cited by
20
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest